自己資本および準備金 変化する 日付
Abbott USD 52.06B 69M 2026-03
Align Technology USD 4.15B 100.27M 2026-03
Anika Therapeutics USD 133.9M 9.56M 2026-03
Arrowhead Research USD 613.98M 45.56M 2026-03
Artivion USD 450.47M 2.24M 2026-03
Baxter International USD 6.04B 86M 2026-03
Boston Scientific USD 25.86B 1.63B 2026-03
EDAP TMS EUR 23.32M 4.5M 2025-09
Edwards Lifesciences USD 10.33B 10.1M 2026-03
Haemonetics USD 796.32M 115.13M 2026-03
Heron Therapeutics USD 9.14M 4.15M 2026-03
J&J USD 81.19B 358M 2026-03
Merit Medical Systems USD 1.63B 42.42M 2026-03
Mesa Laboratories USD 186.69M 8.22M 2025-12
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Option Care Health USD 1.35B 24.68M 2026-03
Stryker USD 22.42B 635M 2025-12
Surmodics USD 111.31M 7.59M 2025-06
Trinity Biotech USD -54.72M 5.18M 2025-09